MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
56.68
-1.41
-2.43%
After Hours: 56.52 -0.16 -0.28% 19:48 12/12 EST
OPEN
57.95
PREV CLOSE
58.09
HIGH
58.50
LOW
55.52
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
78.48
52 WEEK LOW
30.04
MARKET CAP
5.40B
P/E (TTM)
-10.1577
1D
5D
1M
3M
1Y
5Y
1D
2 Healthcare Stocks to Buy Ahead of the New Year
NASDAQ · 2d ago
Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?
NASDAQ · 4d ago
Buy Rating for Crispr Therapeutics AG: Pediatric Market Potential and Long-term Growth Opportunities
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), PROCEPT BioRobotics (PRCT) and Crispr Therapeutics AG (CRSP)
TipRanks · 12/08 12:03
Weekly Report: what happened at CRSP last week (1201-1205)?
Weekly Report · 12/08 10:30
Cathie Wood's weekly recap: heads turn to AI, biotech; sells communication names
Seeking Alpha · 12/08 10:22
Bank of America Securities Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
TipRanks · 12/07 23:55
Crispr Therapeutics AG: Stock Surge Amid Challenges
TipRanks · 12/06 14:02
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.